Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial. McCullough A, Chen CD, Gordon BA, Joseph-Mathurin N, et al. Alzheimers Dement 2025;21:e70347.

Read + Share

Amedeo Smart

Independent Medical Education

McCullough A, Chen CD, Gordon BA, Joseph-Mathurin N, et al. Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial. Alzheimers Dement 2025;21:e70347.
PMID: 40660741